Found 11 matching trials
Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma PHASE1 Multiple myeloma (MM) is the second most common hematologic malignancy with...
Show More Location
Multiple Locations
Learn More & Join Trial
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma PHASE1 The main purpose of this study is to establish a safe and tolerable dose co...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients PHASE1 This study will independently assess the efficacy and safety of 11 combinat...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment PHASE1 The purpose of this study is to characterize the single-dose pharmacokineti...
Show More Location
Winship Cancer Institute, Emory University
Learn More & Join Trial
MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation PHASE1 This is a phase I/II study of MLN9708 for the prophylaxis of chronic graft-...
Show More Location
Froedtert Hospital and the Medical College of Wisconsin
Learn More & Join Trial
Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia PHASE1 This is a phase I study of vincristine, doxorubicin and dexamethasone (modi...
Show More Location
Froedtert Hospital and the Medical College of Wisconsin
Learn More & Join Trial
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction PHASE1 This is a phase 1, 2-part, pharmacokinetic study in patients with advanced ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM PHASE2 This is a single center, open-label, phase 2 study in elderly (age โฅ 70) su...
Show More Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Phase I Study of the Combination of MLN9708 and Fulvestrant PHASE1 Participants in this study will have been diagnosed with advanced breast ca...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial
MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age PHASE1 This research study is evaluating drugs called Millennium 9708 (referred to...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial